EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC-ND 4.0

Targeting HER2 alterations in non-small cell lung cancer: Therapeutic breakthrough and challenges

Ying Yu, Yehao Yang, Hui Li, Yun Fan

Cancer Treatment Reviews · 2023-03 · 114 · 102520

DOI: 10.1016/j.ctrv.2023.102520 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Cancer Treatment Reviews, 2023-03. Verfasst von Ying Yu und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oncology, The Second Clinical Medical College, Zhejiang Chinese Medical University, Hangzhou 310053, China. Electronic address: yuying2…. Hauptthemen laut MEDLINE: Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Immunoconjugates. Die Arbeit wurde bisher 70-mal zitiert (Crossref) und nennt 70 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Zhejiang Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, Non-Small-Cell LungLung NeoplasmsImmunoconjugatesHumansAntibodies, Monoclonal, HumanizedTrastuzumabErb-b2 Receptor Tyrosine KinasesProgression-Free Survival

Stichwörter der Autor:innen

Antibody-drug conjugatesHER2 alterationsHER2-targeted monoclonal antibodiesImmune checkpoint inhibitorsNon-small cell lung cancerselective HER2 tyrosine kinase inhibitors

Substanzen

Antibodies, Monoclonal, HumanizedTrastuzumabErb-b2 Receptor Tyrosine KinasesImmunoconjugates

Autor:innen und Institutionen

  • Department of Oncology, The Second Clinical Medical College, Zhejiang Chinese Medical University, Hangzhou 310053, China. Electronic address: yuying202103@163.com.
  • Wenzhou Medical University, Wenzhou 325000, China. Electronic address: yehao_yang@163.com.
  • Department of Medical Oncology, The Cancer Hospital of the University of Chinese Academy of Sciences (Zhejiang Cancer Hospital), Hangzhou 310022, China; Institute of Cancer Research and Basic Medical Sciences of Chinese…

Förderung

  • National Natural Science Foundation of China
  • Natural Science Foundation of Zhejiang Province

Zitieren

APA

Yu, Y., Yang, Y., Li, H., & Fan, Y. (2023). Targeting HER2 alterations in non-small cell lung cancer: Therapeutic breakthrough and challenges. Cancer Treatment Reviews, 114, 102520. https://doi.org/10.1016/j.ctrv.2023.102520

Vancouver

Yu Y, Yang Y, Li H, Fan Y. Targeting HER2 alterations in non-small cell lung cancer: Therapeutic breakthrough and challenges. Cancer Treatment Reviews. 2023;114:102520. doi:10.1016/j.ctrv.2023.102520

BibTeX
@article{Yu2023,
  author = {Yu, Ying and Yang, Yehao and Li, Hui and Fan, Yun},
  title = {Targeting HER2 alterations in non-small cell lung cancer: Therapeutic breakthrough and challenges},
  journal = {Cancer Treatment Reviews},
  year = {2023},
  volume = {114},
  pages = {102520},
  doi = {10.1016/j.ctrv.2023.102520}
}
Kostenlos starten →